Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies)
- PMID: 7869306
Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies)
Abstract
Objective: To evaluate the efficacy and toxicity of cyclosporine A (CyA) in combination with gold and methotrexate (MTX) in patients with rheumatoid arthritis (RA).
Methods: Twenty patients with RA with partial response to oral MTX and 20 patients with partial response to im gold had CyA added to their regimen for 6 months, withdrawn over 2 months and the patients monitored for 4 months.
Results: There was a significant improvement in joint count, joint score, joint swelling, grip strength and joint pain in patients taking the combination with no significant increase in adverse reactions.
Conclusion: CyA in combination with gold or MTX may, over a 6 month period, increase efficacy in patients with refractory RA without significant increase in toxicity.
Similar articles
-
Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.J Rheumatol. 1998 Aug;25(8):1485-92. J Rheumatol. 1998. PMID: 9712088 Clinical Trial.
-
The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.J Rheumatol. 1999 Oct;26(10):2110-3. J Rheumatol. 1999. PMID: 10529125 Clinical Trial.
-
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.Arthritis Rheum. 2005 May;52(5):1360-70. doi: 10.1002/art.21018. Arthritis Rheum. 2005. PMID: 15880810 Clinical Trial.
-
Current issues of methotrexate and cyclosporine.Curr Opin Rheumatol. 1992 Jun;4(3):309-13. doi: 10.1097/00002281-199206000-00004. Curr Opin Rheumatol. 1992. PMID: 1599808 Review.
-
Combination therapy with cyclosporin in rheumatoid arthritis.Br J Rheumatol. 1996 Sep;35 Suppl 2:19-23. doi: 10.1093/rheumatology/35.suppl_2.19. Br J Rheumatol. 1996. PMID: 8810686 Review.
Cited by
-
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Clin Rev Allergy Immunol. 2017 Jun;52(3):401-423. doi: 10.1007/s12016-016-8582-3. Clin Rev Allergy Immunol. 2017. PMID: 27515671 Review.
-
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.Rheumatol Int. 2005 Jan;25(1):15-22. doi: 10.1007/s00296-003-0384-2. Epub 2003 Oct 7. Rheumatol Int. 2005. PMID: 14530867 Clinical Trial.
-
Combination therapy in rheumatoid arthritis.Springer Semin Immunopathol. 2001;23(1-2):165-83. doi: 10.1007/s002810100069. Springer Semin Immunopathol. 2001. PMID: 11455854 Review. No abstract available.
-
Clinical use of cyclosporin in rheumatoid arthritis.Drugs. 1995;50 Suppl 1:26-36. doi: 10.2165/00003495-199500501-00005. Drugs. 1995. PMID: 8714796 Review.
-
International consensus recommendations on cyclosporin use in rheumatoid arthritis.Drugs. 1995;50 Suppl 1:48-56. doi: 10.2165/00003495-199500501-00008. Drugs. 1995. PMID: 8714799 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical